Earnings History Data for BioCardia, Inc. (BCDA) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
BioCardia, Inc.
BioCardia Inc. is engaged in developing regenerative biologic therapies to treat cardiovascular disease. The company's product candidate consists of CardiAMP(TM), CardiALLO(TM) and Helix Biotherapeutic Delivery System(TM) in clinical development stage. BioCardia Inc. is headquartered in San Carlos, California.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 13-11-2024 | AH | BCDA | BioCardia, Inc. | 4.88 | -0.61 | -1.19 | -1.80 | BioCardia GAAP EPS of -$0.61 beats by $0.58 [11/13/2024 4:26 PM] |
2.03 | -0.32 (-13.66%) |
2.22 | -0.13 (-5.53%) |
1.96 - 23.25 | 142,511 | 40,000 | 4,914 | ||
| 13-08-2024 | AH | BCDA | BioCardia | 5.00 | -0.88 | -0.10 | 0.00 | BioCardia GAAP EPS of -$0.08 beats by $0.02, revenue of $0.03M misses by $0.02M [8/13/2024 4:40 PM] |
2.75 | 0.11 (4.17%) |
2.68 | 0.04 (1.52%) |
2.52 - 23.25 | 71,389 | 10,000 | 1,207 | ||
| 14-05-2024 | AH | BCDA | BioCardia, Inc. | 10.58 | -0.09 | 0.00 | -0.17 | BioCardia GAAP EPS of -$0.09, revenue of $0.05M [5/14/2024 4:14 PM] |
0.3999 | 0.0 (0.98%) |
0.38 | -0.01 (-3.33%) |
0.32 - 2.92 | 90,682 | 210,000 | 442 | ||
| 27-03-2024 | AH | BCDA | BioCardia, Inc. | 8.76 | -0.09 | -0.11 | -0.16 | BioCardia GAAP EPS of -$0.55 misses by $0.09, revenue of $0.5M misses by $0.2M [3/27/2024 4:17 PM] |
0.4137 | -0.01 (-1.29%) |
0.38 | -0.04 (-8.61%) |
0.36 - 2.92 | 216,480 | 180,000 | 64,278 | ||
| 08-11-2023 | AH | BCDA | BioCardia, Inc. | 8.76 | -0.12 | -0.12 | -0.17 | BioCardia GAAP EPS of -$0.12 [11/8/2023 4:51 PM] |
0.41 | -0.02 (-5.75%) |
0.40 | -0.04 (-8.05%) |
0.36 - 2.92 | 67,607 | 40,000 | 361 | ||
| 09-08-2023 | AH | BCDA | BioCardia, Inc. | 18.40 | -0.17 | -0.15 | -0.14 | BioCardia GAAP EPS of -$0.17, revenue of $43M [8/9/2023 4:22 PM] |
0.88 | -0.03 (-3.15%) |
0.86 | -0.05 (-5.34%) |
0.85 - 2.92 | 28,280 | 150,000 | 212 | ||
| 10-05-2023 | AH | 4:05 PM ET (May 10) |
BCDA | BioCardia, Inc. | 41.17 | -0.17 | -0.13 | -0.19 | BioCardia GAAP EPS of -$0.17 in-line [5/10/2023 4:24 PM] |
2.00 | 0.01 (0.50%) |
0.0 | 0.0 (0.00%) |
1.10 - 2.60 | 21,313 | 20,000 | 0 | |
| 09-11-2022 | AH | 4:05 PM ET (Nov 9) |
BCDA | BioCardia, Inc. | 33.21 | -0.17 | -0.23 | -0.16 | BioCardia GAAP EPS of -$0.17, revenue of $0.21M [11/9/2022 4:28 PM] |
1.88 | -0.04 (-2.00%) |
1.85 | -0.07 (-3.57%) |
1.10 - 2.85 | 27,317 | 20,000 | 1,550 | |
|
||||||||||||||||||
| 10-08-2022 | AH | 4:15 PM ET (Aug 10) |
BCDA | BioCardia, Inc. | 27.22 | -0.14 | -0.28 | -0.20 | 1.58 | 0.08 (5.07%) |
1.50 | 0.0 (0.00%) |
1.10 - 3.96 | 46,015 | 40,000 | 169 | ||
| 11-05-2022 | AH | 4:05 PM ET (May 11) |
BCDA | BioCardia, Inc. | 22.68 | -0.19 | -0.15 | -0.18 | BioCardia GAAP EPS of -$0.19, revenue of $0.06M [5/11/2022 4:21 PM] |
1.33 | 0.15 (12.71%) |
1.11 | -0.07 (-5.93%) |
1.10 - 5.10 | 149,516 | 110,000 | 711 | |
| 29-03-2022 | AH | 4:30 PM ET (Mar 29) |
BCDA | BioCardia, Inc. | 36.10 | -0.21 | -0.21 | -0.16 | BioCardia GAAP EPS of -$0.75, revenue of $1M [3/29/2022 4:21 PM] |
2.07 | -0.05 (-2.36%) |
2.12 | 0.0 (0.00%) |
1.25 - 5.10 | 87,895 | 80,000 | 7,669 | |
| 10-11-2021 | AH | After the close (Nov 10) |
BCDA | BioCardia, Inc. | 47.75 | -0.16 | -0.28 | -0.30 | BioCardia reports Q3 results [11/10/2021 5:14 PM] |
2.55 | -0.06 (-2.12%) |
2.75 | -0.02 (-0.72%) |
2.00 - 8.60 | 33,519 | 30,000 | 101 | |
| 13-05-2021 | PM | 8:00 AM ET (May 13) |
BCDA | Biocardia, Inc. | 57.00 | -0.18 | -0.21 | 0.00 | BioCardia reports Q1 results [5/13/2021 9:08 AM] |
3.37 | 0.07 (2.12%) |
0.0 | 0.0 (0.00%) |
1.91 - 8.60 | 64,868 | 50,000 | 0 | |
| 10-11-2020 | PM | BCDA | Biocardia, Inc. | 24.00 | -0.30 | -0.28 | 0.00 | BioCardia EPS misses by $0.01, beats on revenue [11/10/2020 7:22 AM] |
2.05 | 0.13 (6.77%) |
0.0 | 0.0 (0.00%) |
1.91 - 6.75 | 41,068 | 57,087 | 0 | ||
|
|
||||||||||||||||||
| 15-05-2020 | PM | BCDA | BioCardia, Inc. | 28.01 | -0.67 | -0.32 | -0.08 | BioCardia EPS misses by $0.17 [5/15/2020 8:15 AM] |
4.37 | 0.27 (6.59%) |
0.0 | 0.0 (0.00%) |
2.10 - 17.50 | 4,101 | 18,345 | 0 | ||
|
|
||||||||||||||||||